Matter Bio studies DNA from animals and centenarians to find healthy ageing genes
Endpoints News - 22-Apr-2025The aim is to slow ageing by protecting DNA, not reversing it
Endpoints News
News provider covering bipharma’s most comprehensive daily news and updates
Endpoints News is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day.
We produce original editorial on a daily basis on business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. In this organization, the editors have complete authority to call the news as they see it.
Visit website: https://endpts.com/
Details last updated 04-Feb-2019
People at Endpoints News
Articles sourced from Endpoints News
China’s RiboX beats rivals to launch first circular RNA clinical trial
Endpoints News - 04-Apr-2025A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies
Hinge Health is filing for an IPO after cutting losses and boosting revenue
Endpoints News - 10-Mar-2025The IPO could mark a revival in digital health investments
AbbVie joins the obesity drug race with $2.2b Gubra deal
Endpoints News - 03-Mar-2025The pharma giant bets on amylin therapy to enter the weight-loss market
Tuning the future: epigenetic editing breaks new ground in genetic medicine
Endpoints News - 12-Jan-2025Tune Therapeutics secures $175M to pioneer precise gene modulation therapies
FDA approves Humacyte’s lab-grown blood vessels for trauma and bypass surgeries
Endpoints News - 20-Dec-2024Initial use will be in trauma centers due to the product’s complexity
Isomorphic Labs rethinks drug discovery with no labs, just AI
Endpoints News - 12-Dec-2024This aims to reduce development time but faces challenges in proving real-world success
Jupiter Bioventures: transforming early-stage science into biotech success
Endpoints News - 19-Nov-2024A $70m fund takes bold risks to validate ground-breaking ideas and reshape biotech innovation
Iambic’s enchant AI aims to bridge the gap between lab and clinic
Endpoints News - 29-Oct-2024New AI model enhances drug success with precise predictions
Insitro partners with Lilly to advance AI-driven metabolic disease treatments
Endpoints News - 09-Oct-2024A collaboration to develop gene-silencing therapies for fatty liver disease
Clock.bio: New biotech startup aims to extend human healthspan by 20 years
Endpoints News - 31-Aug-2024Revolutionary approach to reverse ageing process with CRISPR gene editing technology
Bit.bio reveals early pipeline of regenerative medicine candidates
Endpoints News - 08-Nov-2023Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025
Genesis Therapeutics lands AI drug discovery deal with Eli Lilly
Endpoints News - 03-May-2022AI-driven biotech teams up with Lilly in a deal worth up to $670 million
Terray Therapeutics unveils game-changing platform for drug discovery
Endpoints News - 15-Feb-2022Combining AI with innovative chemistry to tackle the data bottleneck in medicine development
Apollo Health Ventures raised $180M fund to invest in longevity innovations
Endpoints News - 01-Dec-2021Invests in early stage companies that target root causes of age-related diseases
Reversible reprogramming regenerates cardiac tissue after a heart attack
Endpoints News - 23-Sep-2021Possibility of regeneration: A boon to the broad rejuvenation field
Omega Therapeutics raises $85m for Epigenomic Controllers
Endpoints News - 29-Jul-2020New gene expression therapy for various targets, with clinical trial planned for 2021
Thrive’s CancerSEEK uses blood tests for early multi-cancer detection
Endpoints News - 28-Apr-2020Demonstrated in a large prospective study involving patients without cancer history
British billionaire gambles on an anti-aging upstart
Endpoints News - 26-Jul-2017We are at an inflection point for the treatment of aging. We can generate molecules with specifi...
